Chris Brinsmead joined the Wesleyan Assurance Society's Board on 1 April 2010. "He has over 30 years experience gained nationally and internationally in the pharmaceutical industry, including seven years as President of AstraZeneca Pharma UK Ltd.
"He was previously Chairman of AstraZeneca Pharma UK Ltd and President of the Association of the British Pharmaceutical Industry. Chris has strong business skills and a track record of delivering outstanding results in challenging and complex situations. Chris is currently a business adviser on Life Sciences to the Government, a Non-Executive Director at Domino Printing Sciences plc, United Drug plc, Kinapse Limited and Chairman of Diagnostic Capital Limited." 
Resources and articles
- Wesleyan Assurance Society Board, organizational web page, accessed December 16, 2013.